com【 摘要 】(目的分析急性淋巴细胞白血病(ALL) 患儿经华南地区儿童急性淋巴细胞白血病治疗协作组组 2016( 方案(SCCLG-2016)择治疗后复发的相关因素 。方法选择 2016年 年 8 月至 2017年 年 8 月深 圳市儿童治医院血液肿瘤科收治 A L L 患儿 364 例为研究对象 ,分析 364 例接受 SCCLG-2016 方案治疗的...
目的 通过分析华南地区儿童急性淋巴细胞白血病治疗协作组2016治疗方案(2016 program of the South China children′s acute lymphoblastic leukemia treatment cooperation group, SCCLG-ALL-2016)治疗B细胞起源急性淋巴细胞白血病(B cell acute lymphoblastic leukemia, B-ALL)患儿的临床资料,探讨CD20表达对儿童B-ALL预后的...
Objective To analyze the clinical data of children with B-cell acute lymphoblastic leukemia (B-ALL) treated under the SCCLG-ALL-2016 protocol, to explore the impact of CD20 expression on the prognosis of children with BALL, and to provide a scientifi...
摘要 目的通过分析华南地区儿童急性淋巴细胞白血病治疗协作组2016治疗方案(2016 program of the South China children′s acute lymphoblastic leukemia tre...展开更多 Objective To analyze the clinical data of children with B-cell acute lymphoblastic leukemia(B-ALL)treated under the SCCLG-ALL-2016 protocol,...
摘要 目的 探讨华南地区儿童急性淋巴细胞白血病(ALL)治疗协作组2016治疗方案(SCCLG-ALL-2016)对儿童B细胞起源ALL(B-ALL)中CD20抗原表达与一般临床特点以及预后之间的关系。方法 回顾性分析2016...展开更多 Objective To investigate the relationship between CD20 antigen expression,general clinical features and ...
Prognosis of pediatric BCP‐ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG‐2016 studydoi:10.1111/ejh.14245Background: IKZF1 deletion (IKZF1del) is associated with poor prognosis in B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL). But the ...